Eli Lilly & Co. LLY
$1415.55
-1.13%
at last close
Analyst Consensus
- Consensus Rating
- Buy (21 Buy · 0 Hold · 1 Sell)
- Average Price Target
- $1443.50
- Implied Upside
- +2.0%
- Price Target Range
- $940.00 – $1700.00
- Analysts (12 mo)
- 22
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-17 | RBC CapitalTrung Huynh |
Reiterates | Outperform | $1600 |
| 2026-11-16 | BarclaysEmily Field |
Maintains | Overweight | $1400 → $1550 |
| 2026-11-09 | JefferiesAkash Tewari |
Maintains | Buy | $1610 → $1700 |
| 2026-11-02 | Cantor FitzgeraldCarter Gould |
Maintains | Overweight | $1440 → $1600 |
| 2026-10-30 | UBSMichael Yee |
Maintains | Buy | $1425 → $1625 |
| 2026-10-30 | JP MorganChris Schott |
Maintains | Overweight | $1500 → $1650 |
| 2026-10-30 | CitigroupGeoff Meacham |
Maintains | Buy | $1600 → $1650 |
| 2026-10-30 | ScotiabankLouise Chen |
Maintains | Sector outperform | $1300 → $1605 |
| 2026-10-30 | Morgan StanleyTerence Flynn |
Maintains | Overweight | $1430 → $1596 |
| 2026-10-30 | Wells FargoMohit Bansal |
Maintains | Overweight | $1330 → $1500 |
| 2026-10-30 | Truist SecuritiesSrikripa Devarakonda |
Reiterates | Buy | $1376 → $1612 |
| 2026-10-30 | RBC CapitalTrung Huynh |
Maintains | Outperform | $1500 → $1600 |
| 2026-10-30 | Argus ResearchJasper Hellweg |
Maintains | Buy | $1300 → $1550 |
| 2026-10-21 | Leerink PartnersDavid Risinger |
Maintains | Outperform | $1309 → $1316 |
| 2026-10-12 | RBC CapitalTrung Huynh |
Reiterates | Outperform | $1500 |
| 2026-10-08 | Cantor FitzgeraldCarter Gould |
Maintains | Overweight | $1410 → $1440 |
| 2026-10-07 | Morgan StanleyTerence Flynn |
Maintains | Overweight | $1419 → $1430 |
| 2026-09-28 | JP MorganChris Schott |
Maintains | Overweight | $1400 → $1500 |
| 2026-09-22 | TD CowenSteve Scala |
Reiterates | Buy | $1250 |
| 2026-09-18 | GuggenheimSeamus Fernandez |
Maintains | Buy | $1273 → $1284 |
| 2026-09-10 | HSBCRajesh Kumar |
Maintains | Reduce | $850 → $940 |
| 2026-08-07 | Truist SecuritiesRobyn Karnauskas |
Maintains | Buy | $1370 → $1376 |
| 2026-08-06 | Wells FargoMohit Bansal |
Maintains | Overweight | $1280 → $1330 |
| 2026-08-06 | Cantor FitzgeraldCarter Gould |
Maintains | Overweight | $1350 → $1410 |
| 2026-07-15 | CitigroupGeoff Meacham |
Maintains | Buy | $1500 → $1600 |
| 2026-07-14 | BernsteinCourtney Breen |
Maintains | Outperform | $1300 → $1385 |
| 2026-07-13 | UBSMichael Yee |
Maintains | Buy | $1250 → $1425 |
| 2026-07-13 | GuggenheimSeamus Fernandez |
Maintains | Buy | $1235 → $1273 |
| 2026-07-10 | B of A SecuritiesJason Gerberry |
Maintains | Buy | $1251 → $1334 |
| 2026-07-08 | Truist SecuritiesRobyn Karnauskas |
Maintains | Buy | $1281 → $1370 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $1415.55
- Market Cap
- $1.28 trillion
- 52-Week Range
- $783.85 – $1475.25
- Average Volume
- 2.83 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
